Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
11,650,681
-
Share change
-
+2,702,937
-
Total reported value
-
$205,285,244
-
Put/Call ratio
-
47%
-
Price per share
-
$17.62
-
Number of holders
-
74
-
Value change
-
+$52,201,852
-
Number of buys
-
52
-
Number of sells
-
35
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2015
As of 30 Jun 2015 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 11,650,681 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, Cormorant Asset Management, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, Wildcat Capital Management, LLC, BlackRock Institutional Trust Company, N.A., FRANKLIN RESOURCES INC, Baird Financial Group, Inc., STATE STREET CORP, and DEUTSCHE BANK AG\.
This table shows 74 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.